Borcherding et al. showed the synergistic anti-tumor effect of a TYK2 inhibitor and MEK inhibitor in NF1-associated MPNST in vivo and in vitro [73]. The gene discussed is MAP2K7; the disease is malignant peripheral nerve sheath tumor.